Latest Breaking News On - Regeneron pharmaceuticals daily - Page 25 : comparemela.com

Meyer Handelman Co Acquires 30 Shares of Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Meyer Handelman Co. grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,265 shares of the biopharmaceutical company’s stock after acquiring an additional 30 shares during the quarter. Meyer Handelman Co.’s holdings […]

Christopherr fenimoreAndrewj murphySanfordc bernsteinRegeneron pharmaceuticalsYork mellon corpExchange commissionNews ratings for regeneron pharmaceuticals dailyNorthern trust corpQuarter for regeneron pharmaceuticalsRegeneron pharmaceuticals stock downMeyer handelman coMorgan stanleyCantor fitzgeraldRegeneron pharmaceuticals incJefferies financial groupMeyer handelman

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Shares Bought by Clearview Wealth Advisors LLC

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Shares Bought by Clearview Wealth Advisors LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Arthurf ryanChristopherr fenimoreRegeneron pharmaceuticals price performanceRoyal bankRehmann capital advisory groupRonald blue trust incRegeneron pharmaceuticalsSecurities exchange commissionSutton wealth advisors incCassia capital partnersSmithfield trust coExchange commissionClearview wealth advisorsRegeneron pharmaceuticals profileRegeneron pharmaceuticals incNews ratings for regeneron pharmaceuticals daily

Clearview Wealth Advisors LLC Has $751,000 Holdings in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Clearview Wealth Advisors LLC Has $751,000 Holdings in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesChristopherr fenimoreArthurf ryanQuarter for regeneron pharmaceuticalsMoneta group investment advisorsNorges bankBarclays plcRegeneron pharmaceuticals incClearview wealth advisorsMorgan stanleyNews ratings for regeneron pharmaceuticals dailyJefferies financial groupRegeneron pharmaceuticals stock performanceRegeneron pharmaceuticalsFree reportWealth advisors

Premier Path Wealth Partners LLC Acquires New Shares in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Premier Path Wealth Partners LLC Acquires New Shares in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Arthurf ryanMichaels brownQuarter for regeneron pharmaceuticalsNews ratings for regeneron pharmaceuticals dailyRegeneron pharmaceuticals stock performanceRegeneron pharmaceuticals incJefferies financial groupFortitude family officeCantor fitzgeraldSutton wealth advisors incBruceg allen investmentsPath wealth partnersSunbelt securities incMorgan stanleySecurities exchange commissionRegeneron pharmaceuticals profile

Premier Path Wealth Partners LLC Acquires New Holdings in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

Premier Path Wealth Partners LLC Acquires New Holdings in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Michaels brownChristopherr fenimoreSanfordc bernsteinQuarter for regeneron pharmaceuticalsRegeneron pharmaceuticals stock performanceNews ratings for regeneron pharmaceuticals dailyFortitude family officeJefferies financial groupRegeneron pharmaceuticals incPath wealth partnersBruceg allen investmentsSutton wealth advisors incSunbelt securities incSecurities exchange commissionMorgan stanleyRegeneron pharmaceuticals